Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
PHASE2
This is a single-arm, phase II study of camrelizumab combined with SOX regi...
Status
Active Not Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
PHASE2
Neoadjuvant radiotherapy plus Tegafur, Oxaliplatin and Iparomlimab and Tuvo...
Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE2
To evaluate the initial efficacy and safety of neoadjuvant low-dose interva...
Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
PHASE2
Standard treatment for locally advanced gastric cancer currently involves s...